阿波脂蛋白L3抑制乳腺癌的扩散,并通过P53通路调节细胞循环
1Department of Breast Surgery, The 1st Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
Journal of Cancer
|July 15, 2024
概括
脂蛋白L3 (APOL3) 通过抑制细胞增殖和破坏细胞循环来抑制乳腺癌的生长. 这种蛋白与Y盒结合蛋白1 (YBX1) 相互作用,调节P53通路,提供潜在的治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 乳腺癌是全球癌症死亡率的主要原因之一.
- 脂蛋白L3 (APOL3) 与心血管疾病有关,但其在乳腺癌中的作用尚不清楚.
- 研究APOL3在乳腺癌中的功能对于了解疾病机制至关重要.
研究的目的:
- 阐明阿波利波蛋白L3 (APOL3) 在乳腺癌中的作用和机制.
- 确定APOL3表达和患者预后之间的相关性.
- 确定APOL3相互作用蛋白及其功能意义.
主要方法:
- 利用癌症基因组图谱 (TCGA) 和GEO数据库来获取患者数据.
- 通过qRT-PCR,西部涂抹和IHC评估APOL3表达.
- 在体内评估细胞增殖,细胞循环和瘤生长;使用质谱和CO-IP识别了结合蛋白.
主要成果:
- 乳腺癌中APOL3的表达下调,与预后不佳相关.
- 过度表达APOL3抑制了增殖和诱导细胞循环停止;APOL3倒置促进了增殖.
- APOL3与Y盒结合蛋白1 (YBX1) 相互作用,调解其抗增殖作用.
结论:
- APOL3 抑制乳腺癌细胞的增殖和细胞周期的进展.
- APOL3和YBX1之间的相互作用对APOL3的瘤抑制功能至关重要.
- 准APOL3为乳腺癌治疗提供了一个潜在的治疗策略.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K


